131 related articles for article (PubMed ID: 16026305)
1. Tumour re-differentiation effect of retinoic acid: a novel therapeutic approach for advanced thyroid cancer.
Coelho SM; Vaisman M; Carvalho DP
Curr Pharm Des; 2005; 11(19):2525-31. PubMed ID: 16026305
[TBL] [Abstract][Full Text] [Related]
2. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.
Elisei R; Vivaldi A; Agate L; Ciampi R; Molinaro E; Piampiani P; Romei C; Faviana P; Basolo F; Miccoli P; Capodanno A; Collecchi P; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2005 Apr; 90(4):2403-11. PubMed ID: 15623821
[TBL] [Abstract][Full Text] [Related]
3. Bexarotene via CBP/p300 induces suppression of NF-κB-dependent cell growth and invasion in thyroid cancer.
Cras A; Politis B; Balitrand N; Darsin-Bettinger D; Boelle PY; Cassinat B; Toubert ME; Chomienne C
Clin Cancer Res; 2012 Jan; 18(2):442-53. PubMed ID: 22142826
[TBL] [Abstract][Full Text] [Related]
4. Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2'-deoxycytidine and retinoic acid.
Vivaldi A; Miasaki FY; Ciampi R; Agate L; Collecchi P; Capodanno A; Pinchera A; Elisei R
Mol Cell Endocrinol; 2009 Aug; 307(1-2):142-8. PubMed ID: 19524134
[TBL] [Abstract][Full Text] [Related]
5. Combined effects of all-trans-retinoic acid and trichostatin A on the induction of differentiation of thyroid carcinoma cells.
Yuan GB; Kuang AR; Fan Q; Yu LB; Mi YX
Chin J Cancer; 2010 Apr; 29(4):379-84. PubMed ID: 20346212
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
Hoffmann S; Rockenstein A; Ramaswamy A; Celik I; Wunderlich A; Lingelbach S; Hofbauer LC; Zielke A
Mol Cell Endocrinol; 2007 Jan; 264(1-2):74-81. PubMed ID: 17101211
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of patients treated with retinoic acid for the control of radioiodine non-responsive advanced thyroid carcinoma.
Coelho SM; Vaisman F; Buescu A; Mello RC; Carvalho DP; Vaisman M
Braz J Med Biol Res; 2011 Jan; 44(1):73-7. PubMed ID: 21085896
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of arsenic trioxide in transformed human thyroid cells.
Fröhlich E; Czarnocka B; Brossart P; Wahl R
Thyroid; 2008 Nov; 18(11):1183-93. PubMed ID: 19014326
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid redifferentiation therapy for thyroid cancer.
Schmutzler C; Köhrle J
Thyroid; 2000 May; 10(5):393-406. PubMed ID: 10884186
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid and tributyrin induce in-vitro radioiodine uptake and inhibition of cell proliferation in a poorly differentiated follicular thyroid carcinoma.
Zhang M; Guo R; Xu H; Zhang M; Li B
Nucl Med Commun; 2011 Jul; 32(7):605-10. PubMed ID: 21471848
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid in patients with radioiodine non-responsive thyroid carcinoma.
Coelho SM; Corbo R; Buescu A; Carvalho DP; Vaisman M
J Endocrinol Invest; 2004 Apr; 27(4):334-9. PubMed ID: 15233552
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study.
Simon D; Körber C; Krausch M; Segering J; Groth P; Görges R; Grünwald F; Müller-Gärtner HW; Schmutzler C; Köhrle J; Röher HD; Reiners C
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):775-82. PubMed ID: 12029551
[TBL] [Abstract][Full Text] [Related]
14. Redifferentiation therapy in advanced thyroid cancer.
Haugen BR
Curr Drug Targets Immune Endocr Metabol Disord; 2004 Sep; 4(3):175-80. PubMed ID: 15379720
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients.
Jarzab B; Handkiewicz-Junak D; Roskosz J; Puch Z; Wygoda Z; Kukulska A; Jurecka-Lubieniecka B; Hasse-Lazar K; Turska M; Zajusz A
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1077-86. PubMed ID: 12783219
[TBL] [Abstract][Full Text] [Related]
16. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
[TBL] [Abstract][Full Text] [Related]
17. Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines.
Schreck R; Schnieders F; Schmutzler C; Köhrle J
J Clin Endocrinol Metab; 1994 Sep; 79(3):791-8. PubMed ID: 8077363
[TBL] [Abstract][Full Text] [Related]
18. Effects of retinoids and role of retinoic acid receptors in human thyroid carcinomas and cell lines derived therefrom.
Schmutzler C; Brtko J; Bienert K; Köhrle J
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():16-9. PubMed ID: 8980993
[TBL] [Abstract][Full Text] [Related]
19. Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture.
Fröhlich E; Machicao F; Wahl R
Endocr Relat Cancer; 2005 Jun; 12(2):291-303. PubMed ID: 15947104
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid differentially affects in vitro proliferation, differentiation and mineralization of two fish bone-derived cell lines: different gene expression of nuclear receptors and ECM proteins.
Fernández I; Tiago DM; Laizé V; Leonor Cancela M; Gisbert E
J Steroid Biochem Mol Biol; 2014 Mar; 140():34-43. PubMed ID: 24291400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
